| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 85 | 2023 | 228 | 13.710 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 33 | 2023 | 93 | 8.980 |
Why?
|
| Arthroscopy | 57 | 2022 | 267 | 7.210 |
Why?
|
| Rotator Cuff | 34 | 2022 | 108 | 5.920 |
Why?
|
| Rotator Cuff Injuries | 36 | 2022 | 117 | 4.880 |
Why?
|
| Baseball | 12 | 2022 | 30 | 4.790 |
Why?
|
| Joint Instability | 25 | 2021 | 145 | 3.850 |
Why?
|
| Humans | 181 | 2023 | 12240 | 3.700 |
Why?
|
| Range of Motion, Articular | 48 | 2021 | 278 | 3.600 |
Why?
|
| Shoulder Injuries | 17 | 2022 | 49 | 3.520 |
Why?
|
| Athletic Injuries | 16 | 2020 | 73 | 3.310 |
Why?
|
| Osteoarthritis | 12 | 2023 | 168 | 3.260 |
Why?
|
| Tendon Injuries | 16 | 2019 | 81 | 3.060 |
Why?
|
| Elbow Joint | 15 | 2020 | 52 | 2.980 |
Why?
|
| Tenodesis | 15 | 2022 | 53 | 2.970 |
Why?
|
| Orthopedic Procedures | 17 | 2020 | 111 | 2.930 |
Why?
|
| Shoulder | 20 | 2021 | 92 | 2.830 |
Why?
|
| Treatment Outcome | 60 | 2023 | 1478 | 2.590 |
Why?
|
| Hemiarthroplasty | 6 | 2019 | 18 | 2.550 |
Why?
|
| Male | 95 | 2022 | 6815 | 2.510 |
Why?
|
| Adult | 76 | 2022 | 3557 | 2.510 |
Why?
|
| Shoulder Prosthesis | 9 | 2021 | 15 | 2.300 |
Why?
|
| Humerus | 15 | 2021 | 48 | 2.300 |
Why?
|
| Postoperative Complications | 18 | 2023 | 385 | 2.280 |
Why?
|
| Middle Aged | 76 | 2022 | 4043 | 2.280 |
Why?
|
| Female | 88 | 2022 | 6974 | 2.160 |
Why?
|
| Scapula | 17 | 2022 | 38 | 2.160 |
Why?
|
| Reoperation | 23 | 2020 | 366 | 1.990 |
Why?
|
| Retrospective Studies | 43 | 2023 | 1467 | 1.950 |
Why?
|
| Collateral Ligaments | 5 | 2020 | 13 | 1.940 |
Why?
|
| Collateral Ligament, Ulnar | 5 | 2020 | 10 | 1.920 |
Why?
|
| Return to Sport | 9 | 2021 | 45 | 1.820 |
Why?
|
| Tendons | 13 | 2022 | 74 | 1.770 |
Why?
|
| Shoulder Dislocation | 10 | 2021 | 47 | 1.720 |
Why?
|
| Aged | 53 | 2022 | 4000 | 1.690 |
Why?
|
| Young Adult | 29 | 2022 | 863 | 1.660 |
Why?
|
| Glenoid Cavity | 5 | 2022 | 16 | 1.650 |
Why?
|
| Biomechanical Phenomena | 22 | 2021 | 297 | 1.610 |
Why?
|
| Osteotomy | 7 | 2019 | 66 | 1.580 |
Why?
|
| Ulnar Collateral Ligament Reconstruction | 4 | 2020 | 6 | 1.470 |
Why?
|
| Arthroplasty, Replacement | 7 | 2016 | 49 | 1.440 |
Why?
|
| Follow-Up Studies | 22 | 2021 | 726 | 1.400 |
Why?
|
| Bone Screws | 9 | 2020 | 59 | 1.380 |
Why?
|
| Adolescent | 24 | 2020 | 989 | 1.250 |
Why?
|
| Orthopedics | 3 | 2020 | 32 | 1.240 |
Why?
|
| Ligaments, Articular | 4 | 2019 | 50 | 1.170 |
Why?
|
| Pectoralis Muscles | 4 | 2015 | 10 | 1.140 |
Why?
|
| Arthroplasty | 9 | 2022 | 54 | 1.120 |
Why?
|
| Suture Techniques | 18 | 2019 | 65 | 1.110 |
Why?
|
| Hamstring Muscles | 2 | 2019 | 12 | 1.100 |
Why?
|
| Fracture Fixation, Internal | 2 | 2019 | 33 | 1.090 |
Why?
|
| Shoulder Pain | 10 | 2020 | 24 | 0.990 |
Why?
|
| Tibia | 4 | 2018 | 100 | 0.980 |
Why?
|
| Aged, 80 and over | 20 | 2020 | 2152 | 0.950 |
Why?
|
| Recovery of Function | 11 | 2019 | 118 | 0.940 |
Why?
|
| Shoulder Fractures | 3 | 2016 | 15 | 0.940 |
Why?
|
| Suture Anchors | 7 | 2019 | 39 | 0.900 |
Why?
|
| Evidence-Based Medicine | 6 | 2020 | 78 | 0.890 |
Why?
|
| Radiography | 12 | 2018 | 258 | 0.870 |
Why?
|
| Tendinopathy | 3 | 2015 | 11 | 0.830 |
Why?
|
| Time Factors | 12 | 2020 | 695 | 0.810 |
Why?
|
| Joint Prosthesis | 3 | 2013 | 43 | 0.790 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 13 | 0.760 |
Why?
|
| Treatment Failure | 5 | 2020 | 58 | 0.750 |
Why?
|
| Peripheral Nerve Injuries | 3 | 2020 | 7 | 0.740 |
Why?
|
| Muscle, Skeletal | 9 | 2022 | 201 | 0.730 |
Why?
|
| Fractures, Stress | 2 | 2019 | 11 | 0.710 |
Why?
|
| Athletic Performance | 3 | 2020 | 7 | 0.710 |
Why?
|
| Acromioclavicular Joint | 3 | 2019 | 6 | 0.700 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 38 | 0.680 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 2 | 2012 | 2 | 0.680 |
Why?
|
| Ribs | 2 | 2012 | 3 | 0.680 |
Why?
|
| Arthritis | 3 | 2020 | 16 | 0.670 |
Why?
|
| Pain Measurement | 11 | 2020 | 211 | 0.670 |
Why?
|
| Cadaver | 19 | 2019 | 166 | 0.660 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 18 | 0.650 |
Why?
|
| Patient Reported Outcome Measures | 8 | 2021 | 165 | 0.650 |
Why?
|
| Tenotomy | 3 | 2021 | 6 | 0.630 |
Why?
|
| Bankart Lesions | 1 | 2020 | 9 | 0.630 |
Why?
|
| Athletes | 6 | 2022 | 30 | 0.620 |
Why?
|
| Surveys and Questionnaires | 11 | 2019 | 546 | 0.620 |
Why?
|
| United States | 10 | 2023 | 989 | 0.620 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2020 | 281 | 0.610 |
Why?
|
| Prosthesis Design | 8 | 2020 | 195 | 0.610 |
Why?
|
| Cohort Studies | 10 | 2020 | 827 | 0.600 |
Why?
|
| Patient Selection | 5 | 2013 | 111 | 0.600 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 45 | 0.600 |
Why?
|
| Bone Resorption | 4 | 2019 | 55 | 0.600 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 48 | 0.600 |
Why?
|
| Pandemics | 1 | 2020 | 126 | 0.590 |
Why?
|
| Rotation | 10 | 2021 | 54 | 0.590 |
Why?
|
| Olecranon Process | 1 | 2019 | 3 | 0.590 |
Why?
|
| Patient Satisfaction | 8 | 2021 | 118 | 0.560 |
Why?
|
| Rupture | 8 | 2017 | 41 | 0.540 |
Why?
|
| Body Mass Index | 2 | 2020 | 221 | 0.540 |
Why?
|
| Pneumonia | 1 | 2018 | 33 | 0.540 |
Why?
|
| Patient Readmission | 1 | 2018 | 48 | 0.530 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 32 | 0.530 |
Why?
|
| Humeral Fractures | 1 | 2017 | 7 | 0.530 |
Why?
|
| Databases, Factual | 6 | 2019 | 156 | 0.530 |
Why?
|
| Fever | 1 | 2017 | 18 | 0.530 |
Why?
|
| Electromyography | 1 | 2017 | 22 | 0.520 |
Why?
|
| Sex Factors | 2 | 2017 | 229 | 0.520 |
Why?
|
| Hospital Charges | 1 | 2017 | 9 | 0.520 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 37 | 0.520 |
Why?
|
| Exercise Therapy | 2 | 2017 | 42 | 0.510 |
Why?
|
| Risk Factors | 8 | 2019 | 1049 | 0.500 |
Why?
|
| Finite Element Analysis | 1 | 2016 | 13 | 0.490 |
Why?
|
| Length of Stay | 1 | 2017 | 126 | 0.490 |
Why?
|
| Weight-Bearing | 3 | 2017 | 72 | 0.480 |
Why?
|
| Quality Improvement | 1 | 2016 | 78 | 0.470 |
Why?
|
| Recurrence | 10 | 2021 | 126 | 0.460 |
Why?
|
| Internship and Residency | 2 | 2019 | 103 | 0.460 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2015 | 6 | 0.450 |
Why?
|
| Elbow | 1 | 2015 | 13 | 0.450 |
Why?
|
| Bone Transplantation | 5 | 2019 | 82 | 0.450 |
Why?
|
| Cartilage, Articular | 5 | 2017 | 163 | 0.440 |
Why?
|
| Lacerations | 1 | 2015 | 2 | 0.440 |
Why?
|
| Postoperative Period | 7 | 2021 | 118 | 0.440 |
Why?
|
| Incidence | 7 | 2019 | 338 | 0.430 |
Why?
|
| Acellular Dermis | 1 | 2013 | 1 | 0.390 |
Why?
|
| Skin Transplantation | 1 | 2013 | 8 | 0.390 |
Why?
|
| Foreign-Body Reaction | 1 | 2013 | 6 | 0.390 |
Why?
|
| Wound Healing | 6 | 2017 | 55 | 0.370 |
Why?
|
| Tennis Elbow | 2 | 2009 | 6 | 0.370 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2012 | 3 | 0.360 |
Why?
|
| Arthrodesis | 1 | 2012 | 17 | 0.360 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 15 | 0.360 |
Why?
|
| Prospective Studies | 8 | 2021 | 817 | 0.350 |
Why?
|
| Risk Assessment | 6 | 2013 | 295 | 0.350 |
Why?
|
| Arm | 5 | 2022 | 30 | 0.340 |
Why?
|
| Minimal Clinically Important Difference | 2 | 2021 | 30 | 0.330 |
Why?
|
| Joint Diseases | 4 | 2019 | 44 | 0.330 |
Why?
|
| Pain | 4 | 2022 | 193 | 0.320 |
Why?
|
| Workers' Compensation | 5 | 2021 | 28 | 0.310 |
Why?
|
| Child | 7 | 2020 | 614 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 464 | 0.290 |
Why?
|
| Hand Injuries | 1 | 2009 | 7 | 0.290 |
Why?
|
| Platelet-Rich Plasma | 3 | 2015 | 20 | 0.280 |
Why?
|
| Physical Therapy Modalities | 1 | 2009 | 31 | 0.280 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2020 | 28 | 0.280 |
Why?
|
| Transplantation, Homologous | 5 | 2018 | 93 | 0.270 |
Why?
|
| Patient Positioning | 3 | 2020 | 19 | 0.260 |
Why?
|
| Debridement | 3 | 2019 | 31 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2021 | 81 | 0.250 |
Why?
|
| Transplants | 2 | 2016 | 5 | 0.250 |
Why?
|
| Postoperative Care | 5 | 2020 | 43 | 0.240 |
Why?
|
| Stress, Mechanical | 6 | 2019 | 86 | 0.240 |
Why?
|
| Allografts | 4 | 2021 | 74 | 0.230 |
Why?
|
| Prosthesis Failure | 3 | 2019 | 229 | 0.220 |
Why?
|
| Activities of Daily Living | 4 | 2020 | 182 | 0.210 |
Why?
|
| Age Factors | 4 | 2020 | 350 | 0.210 |
Why?
|
| Equipment Design | 2 | 2020 | 76 | 0.190 |
Why?
|
| Arthroplasty, Subchondral | 2 | 2015 | 14 | 0.190 |
Why?
|
| Tensile Strength | 3 | 2019 | 17 | 0.190 |
Why?
|
| Physical Examination | 2 | 2014 | 37 | 0.190 |
Why?
|
| Depressive Disorder | 1 | 2023 | 90 | 0.180 |
Why?
|
| Osteonecrosis | 1 | 2002 | 9 | 0.180 |
Why?
|
| Injections, Intra-Articular | 2 | 2019 | 31 | 0.180 |
Why?
|
| Computer Simulation | 2 | 2019 | 90 | 0.170 |
Why?
|
| Epilepsy | 2 | 2018 | 36 | 0.170 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2001 | 1 | 0.170 |
Why?
|
| Artificial Limbs | 1 | 2021 | 3 | 0.170 |
Why?
|
| Algorithms | 2 | 2013 | 169 | 0.170 |
Why?
|
| Bone Wires | 2 | 2012 | 3 | 0.170 |
Why?
|
| Movement | 2 | 2016 | 58 | 0.160 |
Why?
|
| Case-Control Studies | 4 | 2016 | 256 | 0.160 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 3 | 0.160 |
Why?
|
| Salvage Therapy | 1 | 2020 | 7 | 0.160 |
Why?
|
| Patient Safety | 1 | 2020 | 16 | 0.160 |
Why?
|
| Ulnar Neuropathies | 1 | 2020 | 4 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2020 | 24 | 0.160 |
Why?
|
| Muscle Strength | 2 | 2017 | 46 | 0.160 |
Why?
|
| Sex | 1 | 2020 | 1 | 0.160 |
Why?
|
| Osseointegration | 1 | 2020 | 53 | 0.160 |
Why?
|
| Anesthesia, Conduction | 1 | 2020 | 15 | 0.160 |
Why?
|
| Sports | 1 | 2020 | 20 | 0.150 |
Why?
|
| Sprains and Strains | 1 | 2019 | 2 | 0.150 |
Why?
|
| Gender Identity | 1 | 2020 | 12 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 38 | 0.150 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 14 | 0.150 |
Why?
|
| Humeral Head | 2 | 2017 | 16 | 0.150 |
Why?
|
| Preoperative Care | 3 | 2020 | 42 | 0.150 |
Why?
|
| Matched-Pair Analysis | 1 | 2019 | 9 | 0.150 |
Why?
|
| Weight Lifting | 1 | 2019 | 5 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2020 | 64 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 423 | 0.150 |
Why?
|
| Ulna | 1 | 2019 | 18 | 0.150 |
Why?
|
| Acromion | 2 | 2021 | 4 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 105 | 0.140 |
Why?
|
| Political Activism | 1 | 2018 | 1 | 0.140 |
Why?
|
| Simulation Training | 1 | 2019 | 15 | 0.140 |
Why?
|
| Health Policy | 1 | 2018 | 20 | 0.140 |
Why?
|
| Orthopedic Nursing | 1 | 1998 | 2 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2018 | 48 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 55 | 0.140 |
Why?
|
| Electroencephalography | 2 | 2018 | 32 | 0.140 |
Why?
|
| Tissue Transplantation | 2 | 2016 | 9 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 68 | 0.140 |
Why?
|
| Surgeons | 1 | 2018 | 43 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 6 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2019 | 96 | 0.130 |
Why?
|
| Pleural Neoplasms | 1 | 2017 | 4 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2017 | 4 | 0.130 |
Why?
|
| Pleura | 1 | 2017 | 5 | 0.130 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 14 | 0.130 |
Why?
|
| Health Care Surveys | 1 | 2017 | 39 | 0.130 |
Why?
|
| Materials Testing | 2 | 2017 | 70 | 0.130 |
Why?
|
| Female Athlete Triad Syndrome | 1 | 2017 | 3 | 0.130 |
Why?
|
| Leg Injuries | 1 | 2017 | 7 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2017 | 7 | 0.130 |
Why?
|
| Osteoporosis | 1 | 2018 | 51 | 0.130 |
Why?
|
| Random Allocation | 4 | 2019 | 59 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2015 | 90 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 141 | 0.130 |
Why?
|
| Sutures | 3 | 2019 | 13 | 0.130 |
Why?
|
| Torque | 2 | 2014 | 8 | 0.130 |
Why?
|
| Patient Preference | 1 | 2017 | 20 | 0.130 |
Why?
|
| Bone Cements | 1 | 2017 | 37 | 0.130 |
Why?
|
| Tarsal Bones | 1 | 2016 | 3 | 0.130 |
Why?
|
| Diagnostic Imaging | 3 | 2016 | 43 | 0.120 |
Why?
|
| Cartilage Diseases | 1 | 2017 | 18 | 0.120 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2017 | 80 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 92 | 0.120 |
Why?
|
| Fracture Fixation | 2 | 2015 | 11 | 0.120 |
Why?
|
| Joint Capsule | 3 | 2008 | 21 | 0.120 |
Why?
|
| Orthopedic Surgeons | 1 | 2016 | 9 | 0.120 |
Why?
|
| Polyethylene | 2 | 2020 | 52 | 0.120 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 100 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 2 | 2009 | 9 | 0.110 |
Why?
|
| Chondrogenesis | 1 | 2015 | 23 | 0.110 |
Why?
|
| Prognosis | 4 | 2011 | 363 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 73 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 247 | 0.110 |
Why?
|
| Thoracic Nerves | 1 | 2015 | 2 | 0.110 |
Why?
|
| Mononeuropathies | 1 | 2015 | 2 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 28 | 0.110 |
Why?
|
| Paralysis | 1 | 2015 | 9 | 0.110 |
Why?
|
| Tendon Transfer | 1 | 2015 | 6 | 0.110 |
Why?
|
| Fibrocartilage | 1 | 2015 | 2 | 0.110 |
Why?
|
| Occupational Injuries | 1 | 2015 | 4 | 0.110 |
Why?
|
| Osteochondritis Dissecans | 1 | 2015 | 11 | 0.110 |
Why?
|
| Thoracic Wall | 2 | 2012 | 5 | 0.110 |
Why?
|
| Return to Work | 1 | 2015 | 18 | 0.110 |
Why?
|
| Arthralgia | 1 | 2015 | 56 | 0.110 |
Why?
|
| Knee Joint | 2 | 2015 | 284 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 400 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 324 | 0.110 |
Why?
|
| Reference Values | 3 | 2010 | 103 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 12 | 0.100 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 18 | 0.100 |
Why?
|
| Boronic Acids | 1 | 2013 | 3 | 0.100 |
Why?
|
| Pyrazines | 1 | 2013 | 7 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 7 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 20 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 25 | 0.100 |
Why?
|
| Femur | 1 | 2015 | 190 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 115 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 128 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 2013 | 20 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 24 | 0.100 |
Why?
|
| Injury Severity Score | 1 | 2013 | 8 | 0.100 |
Why?
|
| Glycoproteins | 2 | 2005 | 30 | 0.100 |
Why?
|
| Acute Disease | 1 | 2013 | 90 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 151 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 99 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 252 | 0.090 |
Why?
|
| Osteocytes | 1 | 2012 | 16 | 0.090 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2012 | 4 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 42 | 0.090 |
Why?
|
| Osteochondritis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Device Removal | 1 | 2011 | 32 | 0.080 |
Why?
|
| Decompression, Surgical | 3 | 2011 | 60 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2010 | 21 | 0.080 |
Why?
|
| Arthrography | 1 | 2010 | 12 | 0.080 |
Why?
|
| Work Capacity Evaluation | 1 | 2010 | 3 | 0.080 |
Why?
|
| Musculoskeletal Pain | 2 | 2020 | 13 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 46 | 0.080 |
Why?
|
| Ilium | 1 | 2010 | 19 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 42 | 0.080 |
Why?
|
| Pain, Postoperative | 2 | 2008 | 146 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2020 | 34 | 0.080 |
Why?
|
| Musculoskeletal Diseases | 1 | 2009 | 19 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 214 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 115 | 0.070 |
Why?
|
| Menisci, Tibial | 1 | 2006 | 41 | 0.060 |
Why?
|
| Hemodiafiltration | 1 | 2005 | 2 | 0.050 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2005 | 3 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 10 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 15 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 61 | 0.050 |
Why?
|
| Bone Density | 1 | 2005 | 110 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2004 | 57 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 70 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 84 | 0.050 |
Why?
|
| Animals | 3 | 2015 | 2092 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2015 | 275 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 40 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2022 | 32 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 31 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 143 | 0.040 |
Why?
|
| Transplantation, Autologous | 2 | 2013 | 42 | 0.040 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2002 | 1 | 0.040 |
Why?
|
| Prothrombin | 1 | 2002 | 4 | 0.040 |
Why?
|
| Arthroscopes | 1 | 2001 | 2 | 0.040 |
Why?
|
| Clavicle | 1 | 2001 | 5 | 0.040 |
Why?
|
| Dermis | 1 | 2020 | 4 | 0.040 |
Why?
|
| Cubital Tunnel Syndrome | 1 | 2020 | 4 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2012 | 186 | 0.040 |
Why?
|
| Bone-Implant Interface | 1 | 2019 | 5 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2019 | 18 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 109 | 0.040 |
Why?
|
| Current Procedural Terminology | 1 | 2019 | 5 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2019 | 8 | 0.040 |
Why?
|
| Software | 1 | 2019 | 26 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 38 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 97 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 158 | 0.030 |
Why?
|
| Depression | 1 | 2020 | 229 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 2 | 0.030 |
Why?
|
| Health Status Indicators | 2 | 2010 | 38 | 0.030 |
Why?
|
| Prosthesis-Related Infections | 1 | 2019 | 98 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 125 | 0.030 |
Why?
|
| Seizures | 1 | 2018 | 35 | 0.030 |
Why?
|
| Coracoid Process | 1 | 2017 | 3 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 9 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 97 | 0.030 |
Why?
|
| Osteolysis | 1 | 2017 | 66 | 0.030 |
Why?
|
| Sports Medicine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 42 | 0.030 |
Why?
|
| Probability | 2 | 2006 | 45 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 1995 | 1 | 0.030 |
Why?
|
| Epilepsies, Partial | 1 | 1995 | 6 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 152 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 1995 | 8 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 7 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 11 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 15 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 74 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 110 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 21 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 67 | 0.030 |
Why?
|
| Bortezomib | 1 | 2013 | 3 | 0.030 |
Why?
|
| Induction Chemotherapy | 1 | 2013 | 8 | 0.030 |
Why?
|
| Vincristine | 1 | 2013 | 15 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2013 | 22 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 34 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2012 | 4 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 47 | 0.020 |
Why?
|
| Leukocytes | 1 | 2012 | 8 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2012 | 13 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 24 | 0.020 |
Why?
|
| Ankle Joint | 1 | 2011 | 21 | 0.020 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 2011 | 3 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 21 | 0.020 |
Why?
|
| Transducers | 1 | 2010 | 7 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 290 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 72 | 0.020 |
Why?
|
| Brain | 1 | 1995 | 707 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 105 | 0.020 |
Why?
|
| Occupations | 1 | 2010 | 8 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 24 | 0.020 |
Why?
|
| Hip Joint | 1 | 2011 | 136 | 0.020 |
Why?
|
| Substance P | 1 | 2008 | 6 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 7 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 10 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 53 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 171 | 0.020 |
Why?
|
| Infant | 2 | 2002 | 277 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2002 | 320 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 124 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2007 | 105 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2006 | 7 | 0.020 |
Why?
|
| Radius | 1 | 2006 | 18 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 191 | 0.010 |
Why?
|
| Selection Bias | 1 | 2005 | 4 | 0.010 |
Why?
|
| Osteoprotegerin | 1 | 2005 | 3 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2005 | 62 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2004 | 7 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2004 | 23 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2004 | 25 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 25 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 168 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 294 | 0.010 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2002 | 6 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 9 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2002 | 30 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2001 | 17 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 312 | 0.010 |
Why?
|
| Elasticity | 1 | 1999 | 19 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1995 | 32 | 0.010 |
Why?
|